InspireMD, Inc.
InspireMD, Inc. (NSPR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nspr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for InspireMD, Inc. (NSPR) measures how much investors pay for each dollar of the company's trailing earnings. NSPR's current PE ratio of N/A is calculated by dividing its stock price of $0.82 by its TTM earnings per share of -$0.51.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2009 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
InspireMD, Inc.You NSPR | $38M | N/A | — | -$0.51 |
 Context Therapeutics Inc. CNTX | $157M | N/A | — | -$0.38 |
 Edap Tms S.a. EDAP | $178M | N/A | — | -$0.78 |
 FONAR Corporation FONR | $118M | 11.34x | — | $1.32 |
 Hyperfine, Inc. HYPR | $119M | N/A | — | -$0.38 |
 ImageneBio Inc IMA | $64M | N/A | — | -$9.31 |
 Microbot Medical Inc. MBOT | $83M | N/A | — | -$0.29 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.66 | — | |
2024-12-31 FY2024 | — | $-0.76 | — | |
2023-12-31 FY2023 | — | $-0.82 | — | |
2022-12-31 FY2022 | — | $-2.35 | — | |
2021-12-31 FY2021 | — | $-2.03 | — | |
2020-12-31 FY2020 | — | $-6.97 | — | |
2019-12-31 FY2019 | — | $-72.06 | — | |
2018-12-31 FY2018 | — | $-235.30 | — | |
2017-12-31 FY2017 | — | $-4265.93 | — | |
2016-12-31 FY2016 | — | $-155793.07 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for InspireMD, Inc. (NSPR) measures how much investors pay for each dollar of the company's trailing earnings. NSPR's current PE ratio of N/A is calculated by dividing its stock price of $0.82 by its TTM earnings per share of -$0.51.
Frequently asked questions
NSPR pe ratio · 6 questionsNSPR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.82 and TTM EPS of -$0.51. Data sourced from Financial Modeling Prep via NSPR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · InspireMD, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09